Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC)

    Predicts survival in HCC patients.
    When to Use

    Do you use the ALBI Grade for HCC and want to contribute your expertise? Join our contributor team!

    mg/dL
    g/dL

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights
    Dr. Philip J. Johnson

    About the Creator

    Philip J. Johnson, MD, FRCP, is a professor in translational oncology at the University of Liverpool. He is also the deputy director of the North West Cancer Research Centre, University of Liverpool. Dr. Johnson’s primary research is focused on diagnosis and prognosis of hepatobiliary and pancreatic cancer.

    To view Dr. Philip J. Johnson's publications, visit PubMed

    Are you Dr. Philip J. Johnson? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
    MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
    About the Creator
    Dr. Philip J. Johnson
    Are you Dr. Philip J. Johnson?